Chagas Disease Treatment Market - Global Industry Insights, Trends, and Opportunity Analysis, 2017-2025
American trypanosomiasis, also referred to as Chagas disease, is caused by the parasite Trypanosoma cruzi (T.cruzi), which is transmitted by the bite of triatomine bugs.
American trypanosomiasis, also referred to as Chagas disease, is caused by the parasite Trypanosoma cruzi (T.cruzi), which is transmitted by the bite of triatomine bugs.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Chagas</strong> <strong>Disease</strong> <strong>Treatment</strong> <strong>Market</strong> -<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS,<br />
OUTLOOK, AND OPPORTUNITY ANALYSIS, <strong>2017</strong>-<br />
<strong>2025</strong><br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Chagas</strong> <strong>Disease</strong> <strong>Treatment</strong> <strong>Market</strong> – Overview<br />
American trypanosomiasis, also referred to as <strong>Chagas</strong> disease, is caused by the parasite Trypanosoma cruzi<br />
(T.cruzi), which is transmitted by the bite of triatomine bugs. T. cruzi can also be transmitted by food contaminated<br />
with the parasite, blood transfusion, transmission from infected mother to newborn during gestational period, organ<br />
transplant, <strong>and</strong> laboratory accidents. Symptoms associated with <strong>Chagas</strong> are not severe <strong>and</strong> often left undiagnosed.<br />
The parasites hide mainly in the heart <strong>and</strong> digestive muscles during the chronic phase of the disease. Years after the<br />
onset of the chronic infection, diseases such as heart diseases (30%), megacolon, <strong>and</strong> megaseophagus are caused.<br />
<strong>Chagas</strong> disease is one of the most neglected parasitic infections in the U.S., however, it is targeted by the Center for<br />
<strong>Disease</strong> Control <strong>and</strong> Prevention (CDC) for community health action. According to Food <strong>and</strong> Drug Administration<br />
(FDA), in <strong>2017</strong>, around 300,000 people are estimated to be affected by <strong>Chagas</strong> disease in the U.S. Furthermore,<br />
World Health Organization (WHO) stated that, around 6 million to 7 million people are expected to be affected by<br />
<strong>Chagas</strong> disease in <strong>2017</strong>, worldwide. Vector control is the most useful method to prevent the spread of <strong>Chagas</strong><br />
disease, especially used in Latin America. High incidence rate <strong>and</strong> easy transmission mode of the disease is<br />
expected to increase the dem<strong>and</strong> for treatment of <strong>Chagas</strong> disease. Non availability of vaccines <strong>and</strong> biological<br />
treatments are expected to create high opportunity for the market players.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Chagas</strong> <strong>Disease</strong> <strong>Treatment</strong> <strong>Market</strong> Taxonomy:<br />
●<br />
By Distribution Channel<br />
– Hospital Pharmacy<br />
– Retail Pharmacy<br />
●<br />
By Region<br />
– North America<br />
– Europe<br />
– Asia Pacific<br />
– Latin America<br />
Request Table of Content Of This Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/934<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Chagas</strong> <strong>Disease</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
●<br />
●<br />
●<br />
●<br />
●<br />
F. Hoffmann-La Roche Ltd.<br />
KaloBios Pharmaceuticals, Inc.<br />
Johnson & Johnson.<br />
Bayer AG.<br />
ELEA SACIF Laboratory.<br />
Adoption of nitro derivative compound drugs associated with the host immune response, help prevent the disease<br />
<strong>and</strong> avoid parasite proliferation. Drugs used in the treatment of <strong>Chagas</strong> disease include benznidazole <strong>and</strong><br />
nifurtimox, however, these are associated with serious side effects such as headaches, skin rashes, photosensitivity,<br />
chest pain, dizziness, nausea, insomnia, <strong>and</strong> jaundice. This poses as a restraining factor for growth of the market.<br />
Browse The Complete Report @<br />
https://www.coherentmarketinsights.com/ongoing-insight/chagas-disease-treatment-market-934<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> <strong>Insights</strong> is a global market intelligence <strong>and</strong> consulting organization<br />
focused on assisting its plethora of clients achieve transformational growth by helping<br />
them make critical business decisions. We are headquartered in India, with an office at<br />
the global financial capital in the U.S. Our client base includes players from across all<br />
business verticals in over 150 countries worldwide. We are uniquely positioned to help<br />
businesses around the globe deliver practical <strong>and</strong> lasting results through various<br />
recommendations about operational improvements, technologies, emerging market<br />
trends <strong>and</strong> new working methods. We offer both customized <strong>and</strong> syndicated market<br />
research reports that help our clients create visionary growth plans to provide traction to<br />
their business. We meticulously study emerging trends across various industries at both<br />
the global <strong>and</strong> regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
SECTOR COVERAGE<br />
Healthcare<br />
CLINICAL DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality <strong>and</strong> Fine Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic Ingredients<br />
Polymers & Resins<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
<strong>Insights</strong> Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEARC<br />
H<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts <strong>and</strong> Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> <strong>Insights</strong> excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, <strong>and</strong><br />
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across<br />
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our<br />
clients achieve better outcomes with uniquely designed <strong>and</strong> highly customized solutions. Our coverage includes insights that help our clients ensure sustained<br />
growth in developed markets <strong>and</strong> also key inputs to help them tap into emerging markets <strong>and</strong> exploit the plethora of opportunities posed therein.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
To k no w mor e abo ut us, v isit o ur web site:<br />
www.coh er en tmark etinsig hts.com<br />
For sales q ueries o r new top ics email u s o n :<br />
sales@coh er en tmark etinsig hts.co m<br />
Fo r o th er q uer ies co n tact:<br />
Mr. Sh ah<br />
( Man ag er - Business Dev elo pment)<br />
Co herent Mark et Insig hts<br />
sales@coh er en tmark etinsig hts.co m<br />
+1 -2 06 -7 0 1- 67 02<br />
THANK YOU<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
Change language